AAAAAA
Results:
1-20
|
Results: 20
Authors:
Llovet, JM
Ruff, P
Tassopoulos, N
Castells, L
Bruix, J
El-Hariry, I
Peachey, M
Citation: Jm. Llovet et al., A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma, EUR J CANC, 37(11), 2001, pp. 1352-1358
Authors:
Llovet, JM
Vilana, R
Bru, C
Bianchi, L
Bruix, J
Citation: Jm. Llovet et al., Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma - Reply, HEPATOLOGY, 34(3), 2001, pp. 610-611
Authors:
Gimenez-Barcons, M
Franco, S
Suarez, Y
Forns, X
Ampurdanes, S
Puig-Basagoiti, F
Sanchez-Fueyo, A
Barrera, JM
Llovet, JM
Bruix, J
Sanchez-Tapias, JM
Rodes, J
Saiz, JC
Citation: M. Gimenez-barcons et al., High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis, HEPATOLOGY, 34(1), 2001, pp. 158-167
Authors:
Sarasin, FP
Majno, PE
Llovet, JM
Bruix, J
Mentha, G
Hadengue, A
Citation: Fp. Sarasin et al., Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective, HEPATOLOGY, 33(5), 2001, pp. 1073-1079
Authors:
Bruix, J
Sherman, M
Llovet, JM
Beaugrand, M
Lencioni, R
Burroughs, AK
Christensen, E
Pagliaro, L
Colombo, M
Rodes, J
Citation: J. Bruix et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference, J HEPATOL, 35(3), 2001, pp. 421-430
Authors:
Bruix, J
Llovet, JM
Citation: J. Bruix et Jm. Llovet, Hepatocellular carcinoma: is surveillance cost effective?, GUT, 48(2), 2001, pp. 149-150
Authors:
Llovet, JM
Sala, M
Bruix, J
Citation: Jm. Llovet et al., Nonsurgical treatment of hepatocellular carcinoma, LIVER TRANS, 6(6), 2000, pp. S11-S15
Authors:
Llovet, JM
Bruix, J
Citation: Jm. Llovet et J. Bruix, Early diagnosis and treatment of hepatocellular carcinoma, BEST PR RES, 14(6), 2000, pp. 991-1008
Authors:
Llovet, JM
Bruix, J
Citation: Jm. Llovet et J. Bruix, Prospective validation of the cancer of the Liver Italian Program (CLIP) score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma, HEPATOLOGY, 32(3), 2000, pp. 679-680
Authors:
Llovet, JM
Bruix, J
Gores, GJ
Citation: Jm. Llovet et al., Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy, HEPATOLOGY, 31(4), 2000, pp. 1019-1021
Authors:
Llovet, JM
Sala, M
Castells, L
Suarez, Y
Vilana, R
Bianchi, L
Ayuso, C
Vargas, V
Rodes, J
Bruix, J
Citation: Jm. Llovet et al., Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma, HEPATOLOGY, 31(1), 2000, pp. 54-58
Authors:
Johnson, P
Bruix, J
Citation: P. Johnson et J. Bruix, Hepatocellular carcinoma and the art of prognostication, J HEPATOL, 33(6), 2000, pp. 1006-1008
Authors:
Llovet, JM
Moitinho, E
Sala, M
Bataller, R
Rodriguez-Iglesias, P
Castells, A
Fernandez, J
Planas, R
Navasa, M
Bruix, J
Rodes, J
Citation: Jm. Llovet et al., Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis, J HEPATOL, 33(3), 2000, pp. 423-429
Authors:
Bruix, J
Llovet, JM
Citation: J. Bruix et Jm. Llovet, Locoregional treatments for hepatocellular carcinoma, BEST PR RES, 13(4), 1999, pp. 611-622
Authors:
Bruix, J
Bru, C
Citation: J. Bruix et C. Bru, Rationale for non-surgical interventional treatment of hepatocellular carcinoma, MED RADIOL, 1999, pp. 245-253
Authors:
Llovet, JM
Bru, C
Bruix, J
Citation: Jm. Llovet et al., Prognosis of hepatocellular carcinoma: The BCLC staging classification, SEM LIV DIS, 19(3), 1999, pp. 329-338
Authors:
Llovet, JM
Fuster, J
Bruix, J
Citation: Jm. Llovet et al., Intention-to-treat analysis of surgical treatment for early hepatocellularcarcinoma: Resection versus transplantation, HEPATOLOGY, 30(6), 1999, pp. 1434-1440
Authors:
Llovet, JM
Bustamante, J
Castells, A
Vilana, R
Ayuso, MD
Sala, M
Bru, C
Rodes, J
Bruix, J
Citation: Jm. Llovet et al., Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials, HEPATOLOGY, 29(1), 1999, pp. 62-67
Authors:
Gimenez-Barcons, M
Forns, X
Ampurdanes, S
Guilera, M
Soler, M
Soguero, C
Sanchez-Fueyo, A
Mas, A
Bruix, J
Sanchez-Tapias, JM
Rodes, J
Saiz, JC
Citation: M. Gimenez-barcons et al., Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases, J HEPATOL, 30(6), 1999, pp. 1028-1034
Authors:
Suarez, Y
Sala, M
Llovet, JM
Bruix, J
Citation: Y. Suarez et al., Diagnosis and treatment of hepatocellular carcinoma, ACT GASTR B, 62(4), 1999, pp. 410-414
Risultati:
1-20
|